期刊文献+

选择性iNOS抑制剂对肝硬化大鼠门脉高压性胃黏膜病变的影响 被引量:1

Effect of iNOS inhibitor on portal hypertensive gastropathy in cirrhotic rats
下载PDF
导出
摘要 目的:探讨选择性诱导型一氧化氮合酶抑制剂氨基胍(aminoguanidine,AG)对肝硬化大鼠门脉高压性胃黏膜病变的防治作用及其机制.方法:将SD大鼠30只随机分为对照组(n=10)、模型组(n=10)和AG组(n=10),予400mL/LCCl4皮下注射12wk建立肝硬化大鼠模型,AG组为皮下注射CCl4同时予AG饮用.观察比较各组大鼠胃黏膜形态及组织学变化,应用免疫组化法检测胃黏膜诱导型一氧化氮合酶(iNOS)的表达,并测定胃黏膜溃疡指数、门静脉压力.结果:AG组胃黏膜病变程度较模型组减轻,溃疡指数明显低于模型组(3.00±2.31vs10.60±3.47,P<0.01);模型组胃黏膜iNOS吸光度、面密度值均较对照组增高(0.64±0.04vs0.25±0.03;0.344±0.068vs0.017±0.008,均P<0.01),AG组胃黏膜iNOS吸光度值、面密度值(0.46±0.09,0.159±0.021)均较模型组明显下降(均P<0.01).AG组门脉压力较模型组降低.结论:AG可在一定程度上减轻门脉高压性胃黏膜病变,其机制可能主要通过抑制胃黏膜iNOS表达. AIM: To investigate the effect and mechanism of aminoguanidine (AG) on the portal hypertensive gastropathy in cirrhotic rats. METHODS: Thirty male SD rats were randomly divided into three groups: control group (n = 10), model group (n = 10) and AG treatment group (n = 10) (AG group). The model group was induced through subcutaneous injection of CCl4 for 12 weeks, AG group was given subcutaneous injection of CCl4 together with oral administration of AG. The morphological and histological changes in gastric mucosa were evaluated. The expres- sion of iNOS in gastric mucosa was detected by SABC immunohistochemical methods. And the ulcer-index (UI) of gastric mucosa, and portal pressure were measured in each group. RESULTS: Histological changes of gastric mu-cosa was milder and ulcer index of gastric mucosa was significantly lower in AG group than in model group (3.00 ± 2.31 vs 10.60 ±3.47, P 〈 0.01). The expression of iNOS (optical density and area density) in gastric mucosa was signifi cantly higher in model group than in control group (0.64 ± 0.04 vs 0.25 ± 0.03; 0.344 ± 0.068 vs 0.017 ± 0.008, both P 〈 0.01). Optical density and area density were significantly lower in AG group than in model group (0.46 ±0.09 vs 0.64 ± 0.04; 0.159 ± 0.021 vs 0.344 ± 0.068, both P 〈 0.01), and the portal pressure were lower in AG group than in model group. CONCLUSION: Aminoguanidine may ame- liorate the development of portal hypertensive gastropathy through significantly inhibiting the expression of iNOS in gastric mucosa.
出处 《世界华人消化杂志》 CAS 北大核心 2009年第8期813-816,共4页 World Chinese Journal of Digestology
关键词 氨基胍 诱生型一氧化氮合酶 肝硬化 门脉高压性胃病 Aminoguanidine Inducible nitric oxidesynthase Cirrhosis Portal hypertensive gastropathy
  • 相关文献

参考文献18

  • 1de Franchis R, Primignani M. Natural history of portal hypertension in patients with cirrhosis. Clin Liver Dis 2001; 5:645-663. 被引量:1
  • 2余立凯,尹朝礼,唐望先,但自力.一氧化氮与大鼠门脉高压胃粘膜病变关系的实验研究[J].同济医科大学学报,2001,30(2):160-162. 被引量:1
  • 3Wei CL, Hon WM, Lee KH, Khoo HE. Chronic administration of aminoguanidine reduces vascular nitric oxide production and attenuates liver damage in bile duct-ligated rats. Liver Int 2005; 25:647-656. 被引量:1
  • 4Lee FY, Wang SS, Tsai YT, Lin HJ, Lin HC, Chu CJ, Wu SL, Tai CC, Lee SD. Aminoguanidine corrects hyperdynamic circulation without ameliorating portal hypertension and portal hypertensive gastropathy in anesthetized portal hypertensive rats. J Hepatol.1997; 26:687-693. 被引量:1
  • 5Soulis-Liparota T, Cooper M, Papazoglou D, Clarke B, Jerums G. Retardation by aminoguanidine of development of albuminuria, mesangial expansion, and tissue fluorescence in streptozocin-induced diabetic rat. Diabetes 1991; 40:1328-1334. 被引量:1
  • 6Lo SK, Leung FW, Guth PH. IJrotection against absolute-ethanol-induced gastric antral and corpus mucosal injury. A gross and histologic study. Dig Dis Sci 1988; 33:1403-1408. 被引量:1
  • 7Schneider AR, Benz C, Adamek HE, Jakobs R, Riemann JF, Arnold JC. Minilaparoscopy versus conventional laparoscopy in the diagnosis of hepatic diseases. Gastrointest Endosc 2001; 53: 771-775. 被引量:1
  • 8Tsugawa K, Hashizume M, Migou S, Kishihara F, Kawanaka H, Tomikawa M, Tanoue K, Sugimachi K. Role of nitric oxide and endothelin-1 in a portal hypertensive rat model. Scand J Gastroenterol 2000;35:1097-1105. 被引量:1
  • 9Helmer KS, West SD, Shipley GL, Chang L, Cui Y, Mailman D, Mercer DW. Gastric nitric oxide synthase expression during endotoxemia: implications in mucosal defense in rats. Gastroenterology 2002; 123:173-186. 被引量:1
  • 10Tarnawski AS, Tomikawa M, Kawanaka H. Increased oxygen free radicals, nitrotyrosine and enhanced lipid peroxydation in portal hypertensive gastric mucosa: A key to increased susceptibility to injury. Gastroenterology 1999; 116:A1282. 被引量:1

二级参考文献22

  • 1张丕利,梁扩寰,张文英,林菊生,尹朝礼.一氧化氮在肝硬化鼠动脉扩张中的作用 [J].中华消化杂志,1995,15(6):333-335. 被引量:8
  • 2魏丽春,郭鹞.肠型放射病时小鼠小肠壁内一氧化氮合酶的动态分布[J].第四军医大学学报,1995,16(1):13-16. 被引量:6
  • 3张丕利,程冬梅,梁扩寰,尹朝礼.肝硬化大鼠胃壁一氧化氮合酶的组化研究[J].胃肠病学和肝病学杂志,1997,6(1):49-51. 被引量:4
  • 4Fehrenbach H,Weiskirchen R,Kasper M,et al.Up-regulated expression of the receptor for advanced glycation end products in cultured rat hepatic stellate cells during transdifferentiation to myofibroblasts.Hepatology,2001,34:943-952. 被引量:1
  • 5Zeng S,Feirt N,Goldstein M,et al.Blockade of receptor for advanced glycation end product (RAGE) attenuates ischemia and reperfusion injury to the liver in mice.Hepatology,2004,39:422-432. 被引量:1
  • 6Murawaki Y,Ikuta Y,Koda M,et al.Clinical significance of serum hyaluronan in patients with chronic viral liver disease.J Gastroenterol Hepatol,1996,11:459-465. 被引量:1
  • 7Clot P,Tabone M,Arico S,et al.Monitoring oxidative damage in patients with liver cirrhosis and different daily alcohol intake.Gut,1994,35:1637-1643. 被引量:1
  • 8Liehr H,Grun M,Brunswig D,et al.Letter:Endotoxaemia in liver cirrhosis:treatment with polymyxin B.Lancet,1975,1:810-811. 被引量:1
  • 9Giardino I,Fard AK,Hatchell DL,et al.Aminoguanidine inhibits reactive oxygen species formation,lipid peroxidation,and oxidantinduced apoptosis.Diabetes,1998,47:1114-1120. 被引量:1
  • 10Sebekova K,Kupcova V,Schinzel R,et al.Markedly elevated levels of plasma advanced glycation end products in patients with liver cirrhosis-amelioration by liver transplantation.J Hepatol,2002,36:66-71. 被引量:1

共引文献9

同被引文献22

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部